Boston Scientific Announces its First Transaction of 2025 for $443 Million
Boston Scientific announced its first deal of 2025. On January 8, Boston Scientific reported that it was acquiring the remaining 74% stake of Bolt Medical for $443 million, plus potential regulatory milestone payments of up to $221 million. Bolt Medical is based in Carlsbad, California. It is a developer and manufacturer of an intravascular lithotripsy advanced laser-based platform for treating coronary and peripheral artery disease. The company is concurrently studying three unique catheter platforms for various arterial vessel beds. Boston Scientific helped establish Bold Medical in 2019 and prior to this transaction owned a 26% stake in the company. With headquarters... Read More »
Stryker Kicks Off 2025, Striking $4.9 Billion Inari Medical Deal
Medical device maker Stryker Corp. kicked off 2025 with a massive transaction. The Kalamazoo, Michigan-based company announced that it has agreed to acquire Inari Medical, headquartered in Irvine, California. Under the terms of the deal, which was first reported by Reuters on January 6, 2024, Stryker will pay $80 per share for Inari. The all-cash deal is worth $4.9 billion. Founded in 2013, Inari Medical Inc is a maker of devices and systems that treat patients suffering from a variety of blood clot conditions including pulmonary embolism, deep vein thrombosis and in-stent thrombosis, which occurs when blood clots form in the devices used to prop open coronary arteries that have been... Read More »
Boston Scientific to Acquire Intera Oncology
Boston Scientific Corporation announced on November 25 that it has entered into a definitive agreement to acquire Newton, Massachusetts-based Intera Oncology Inc. Intera Oncology is a privately held medical device company that provides the Intera 3000 Hepatic Artery Infusion Pump and floxuridine – a chemotherapy drug – both of which are approved by the U.S. Food and Drug Administration. The Intera 3000 pump is used to administer hepatic artery infusion therapy to treat tumors in the liver primarily caused by metastatic colorectal cancer. Boston Scientific develops and manufactures minimally invasive medical devices used in interventional cardiology, cardiac rhythm management, peripheral... Read More »
Earnings Week in Review: Navigating Challenges and Growth in Q3 2024 Healthcare
We’re taking a look at some of the major companies reporting earnings in the week of October 28 – November 1, across a variety of sectors. Managed Care providers Humana and Cigna reported significant growth, driven by their health insurance offerings. The eHealth space saw Teladoc Health and American Well Corp. navigating competitive pressures and market shifts, highlighting the dynamic nature of digital health. Meanwhile, Stryker Corp.’s strong earnings performance in the Medical Devices segment contrasted with Avanos Medical’s struggle with cost pressures. These earnings reports offer a comprehensive view of the healthcare industry’s current performance and future... Read More »
Archimed Strengthens Presence in Occupational Health Medical Device Market With Acquisition
Global private equity healthcare specialist Archimed announced on October 16 that it has acquired FIM Medical. The company is being acquired by ArchiMed’s latest fund, MED Rise, which closed on €400 million (approximately USD $436 million) in April 2024. FIM Medical is a prominent company in the French occupational health medical device market. The company is a designer, manufacturer and supplier of medical screening devices. It provides vision, hearing and respiratory care products, using proprietary technology in both its medical devices and software. ArchiMed is an independent investment firm focused exclusively on healthcare industries. It has directly managed and invested in... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
